# Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection

> **NCT01500512** · — · UNKNOWN · sponsor: **Gynecologic Oncology Group** · enrollment: 148 (actual)

## Conditions studied

- Stage I Vulvar Cancer
- Stage II Vulvar Cancer
- Stage III Vulvar Cancer
- Vulvar Squamous Cell Carcinoma

## Interventions

- **OTHER:** Clinical Observation

## Key facts

- **NCT ID:** NCT01500512
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01-03
- **Primary completion:** 2022-07-01
- **Final completion:** —
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2021-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500512, "Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01500512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
